- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Theravance Biopharma (TBPH)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 175.61 mm | 175.61 mm | 175.61 mm | 175.61 mm | 175.61 mm | 175.61 mm |
| Cash burn (monthly) | 35.72 mm | (no burn) | 2.15 mm | (no burn) | 2.17 mm | (no burn) |
| Cash used (since last report) | 81.46 mm | n/a | 4.91 mm | n/a | 4.95 mm | n/a |
| Cash remaining | 94.15 mm | n/a | 170.70 mm | n/a | 170.66 mm | n/a |
| Runway (months of cash) | 2.6 | n/a | 79.3 | n/a | 78.7 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 127 |
| Opened positions | 23 |
| Closed positions | 15 |
| Increased positions | 43 |
| Reduced positions | 33 |
| 13F shares | Current |
|---|---|
| Total value | 409.68 bn |
| Total shares | 44.89 mm |
| Total puts | 300.00 |
| Total calls | 600.00 |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| Madison Avenue Partners | 9.51 mm | $89.50 bn |
| Weiss Asset Management | 7.46 mm | $70.17 bn |
| Newtyn Management | 4.76 mm | $44.77 bn |
| BlackRock | 3.71 mm | $34.93 bn |
| Irenic Capital Management | 2.76 mm | $25.98 bn |
| Vanguard | 2.01 mm | $18.92 bn |
| Park West Asset Management | 1.79 mm | $16.87 bn |
| STT State Street | 1.22 mm | $11.50 bn |
| Oasis Management | 1.12 mm | $10.50 bn |
| Camber Capital Management | 1.00 mm | $9.41 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Dec 25 | Rhonda Farnum | Ordinary Shares | Sell | Dispose S | No | No | 18.7493 | 15,534 | 291.25 k | 277,695 |
| 3 Dec 25 | Rhonda Farnum | Ordinary Shares | Sell | Dispose S | No | No | 18.7508 | 7,766 | 145.62 k | 293,229 |
| 3 Dec 25 | Rhonda Farnum | Ordinary Shares | Sell | Dispose S | No | No | 18.7499 | 7,767 | 145.63 k | 300,995 |
| 26 Nov 25 | Broshy Eran | Ordinary Shares | Sell | Dispose S | No | Yes | 20 | 15,501 | 310.02 k | 44,703 |
| 26 Nov 25 | Broshy Eran | Ordinary Shares | Sell | Dispose S | No | Yes | 20 | 14,000 | 280.00 k | 60,204 |
| 26 Nov 25 | Broshy Eran | Share Option Ordinary Shares | Option exercise | Acquire M | No | No | 10.15 | 14,000 | 142.10 k | 81,749 |
| 20 Nov 25 | Rhonda Farnum | Ordinary Shares | Payment of exercise | Dispose F | No | No | 17.9 | 9,060 | 162.17 k | 308,762 |
| 20 Nov 25 | Brett A. Grimaud | Ordinary Shares | Payment of exercise | Dispose F | No | No | 17.9 | 19,024 | 340.53 k | 355,282 |
| 20 Nov 25 | Aine Miller | Ordinary Shares | Payment of exercise | Dispose F | No | No | 17.9 | 6,989 | 125.10 k | 201,012 |